5-ASAs/mesalazine May Lower Colorectal Cancer Risk in Inflammatory Bowel Disease (IBD)
-More evidence that taking your medication does a body good: Results of a recent study from the UK suggests that Inflammatory Bowel Disease patients (IBD) who take their 5-ASA/mesalazine medicine…
Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center Announce Drug Discovery Collaboration Agreement
-COPENHAGEN, DK. and BOSTON, MASS. — Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center (BIDMC) today announced they have signed a collaborative agreement to…
Ferring and Johnson & Johnson Join in a Research Collaboration
-Ferring announced today that it will collaborate with Ortho-McNeil Pharmaceuticals Inc. (Ortho-McNeil) and Ortho-McNeil’s research affiliate, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)…
Ferring appoints new Board member
-The Board of Directors of Ferring announced this week that Professor Michael Rosenblatt has been appointed to the Group Board…
Ferring Appoints New Vice-President of Global Marketing
-Ferring would like to announce that Mr. Aaron Graff has been appointed as Vice President of Global Marketing, Medical Services and Business Development…
